▎ 摘　　要

NOVELTY - Hemostatic material comprises 5-10 pts. wt. sodium- beta -cyclodextrin metal organic framework, 50-60 pts. wt. 4-hydroxybutyl acrylate glycidyl ether modified hyperbranched polylysine, 1-2 pts. wt. allyl B-D glucopyranoside modified graphene quantum dots, 8-12 pts. wt. incense ash, 1-3 pts. wt. 4-methacrylamidosalicylic acid, 0.5-1.5 pts. wt. coupling agent, and 0.05-0.08 pts. wt. initiator. USE - The hemostatic material is used for infant (claimed). ADVANTAGE - The hemostatic material has high hemostatic efficiency, little irritation to infant tissues, high safety, little toxic side effects, and high clinical practical value. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for preparation of the hemostatic material comprising uniformly mixing the raw materials to obtain mixed material, adding into twin-screw extruder, extrusion molding, cooling to room temperature, and sterilizing.